Info@ThinkPinkRocks.com

NeoGenomics launches 23 NGS-based NeoTYPE Cancer Profiles

NeoGenomics, Inc., a leading provider of cancer-focused genetic and molecular testing services, announced today it has launched 23 new and innovative NeoTYPE Cancer Profiles based on next-generation sequencing (NGS).

See original article:
NeoGenomics launches 23 NGS-based NeoTYPE Cancer Profiles

Share

Leave a Reply

Solve : *
26 − 19 =